Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.

By Bart C. J. M. Fauser, B. Tarlatzis, R. Rebar, R. Legro, A. Balen, R. Lobo, E. Carmina, Jeffrey Chang, B. Yıldız, J. Laven and 9 more. Fertility and Sterility, 2012

1,611 citations recorded by the source corpus.

Subfields: Public Health, Environmental and Occupational Health, Reproductive Medicine

View Paper: https://www.semanticscholar.org/paper/654958cc90adb2c1086f3a598ff8f6911638fba1

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Public Health, Environmental and Occupational Health

1. Kristen A Pate
2. Susan M. Sirmans
3. E. Diamanti-Kandarakis
4. Didier Dewailly

In Reproductive Medicine

1. H. Escobar-Morreale
2. Kristen A Pate
3. Susan M. Sirmans
4. E. Diamanti-Kandarakis
5. Didier Dewailly

Citations in the corpus

• The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. (2014, positive): “In 2011, the Amsterdam ESHRE/ ASMR-sponsored 3rd PCOS Consensus Workshop Group (10) identified different phenotypes, and separated the most classic phenotype, characterised by hyperandro-genism and CA, from those characterised by ovarian dysfunction and polycystic morphology.”
• Epidemiology, diagnosis, and management of polycystic ovary syndrome (2013, methodology): “It generally takes at least 6 months of treatment to see a response due to the growth cycle of hair.(6) Antiandrogens can be added if there has been no improvement after 6 months of treatment.”